Ask AI
MK-8591A-054
MK-8591A-054: Interim Analysis of Safety and Efficacy of Reduced-Dose DOR/ISL in People Living With Virologically Suppressed HIV

Released: October 29, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: October 29, 2025